|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kaleido Biosciences, Inc. (KLDO) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/23
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
35,550,000 |
| Market
Cap: |
3.56(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.0002 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kaleido Biosciences is a clinical-stage healthcare company with an approach focused on utilizing the microbiome to treat disease and improve human health. Co.'s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the existing microbes. Co. has an approach to the discovery and development of MMTs, and its initial MMTs are targeted glycans. Each targeted glycan is an ensemble of complex carbohydrates that is intended to modulate microbial metabolism and community composition to drive a specific biological response.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Korn Jerald |
COO & General Counsel |
• – – |
2022-02-28 |
4 |
D |
$1.49 |
$3,049 |
D/D |
(2,046) |
4,517 |
|
- |
|
| Van Hylckama Vlieg Johan |
Chief Scientific Officer |
• – – |
2022-02-28 |
4 |
D |
$1.49 |
$3,110 |
D/D |
(2,087) |
4,620 |
|
- |
|
| Menichella Daniel L |
Chief Executive Officer |
• • – |
2021-02-08 |
4 |
B |
$11.50 |
$230,000 |
D/D |
20,000 |
20,000 |
2.81 |
-41% |
|
| Afeyan Noubar |
10% Owner |
– – • |
2021-02-08 |
4 |
B |
$11.50 |
$2,472,500 |
I/I |
215,000 |
738,333 |
1.5 |
-41% |
|
| Nutritional Health Ltp Fund, L.p. |
10% Owner |
– – • |
2020-06-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
666,666 |
|
24% |
|
| Afeyan Noubar |
10% Owner |
– – • |
2020-06-04 |
4 |
B |
$7.50 |
$15,000,000 |
I/I |
2,000,000 |
666,666 |
1.5 |
24% |
|
| Melas Kyriazi Theo |
Director |
– • – |
2020-06-04 |
4 |
B |
$7.50 |
$249,998 |
D/D |
33,333 |
33,333 |
2.39 |
24% |
|
| Afeyan Noubar |
Director |
– • • |
2019-03-04 |
4 |
B |
$15.00 |
$13,999,995 |
I/I |
933,333 |
2,244,305 |
2.25 |
- |
|
| Afeyan Noubar |
Director |
– • • |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
11,070,951 |
1,910,972 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,120,697 |
947,111 |
|
- |
|
| Bonney Michael W |
Executive Chair |
• • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
225,000 |
225,000 |
|
- |
|
| Bonney Michael W |
Executive Chair |
• • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
417,673 |
1,426,196 |
|
- |
|
| Quinn Anthony |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,853 |
31,603 |
|
- |
|
| Von Maltzahn Geoffrey |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
342,466 |
342,466 |
|
- |
|
| Bonney Michael W |
Executive Chair |
• • – |
2019-02-28 |
4 |
B |
$13.95 |
$999,493 |
D/D |
71,520 |
1,008,523 |
2.81 |
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,735,729 |
|
- |
|
| Quinn Anthony |
Director |
– • – |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,750 |
|
- |
|
| Afeyan Noubar |
Director |
– • • |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,500,000 |
|
- |
|
| Lawton Alison Francis |
See RemarksOfficer |
• • – |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
165,000 |
|
- |
|
| Bonney Michael W |
Executive ChairOfficer |
• • – |
2019-02-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
937,003 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
